Global Pharmaceuticals & Biotech Most Popular Stocks

Eli Lilly

Market Cap: US$935.4b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$575.0b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

AbbVie

Market Cap: US$394.6b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Roche Holding

Market Cap: CHF 280.3b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Novartis

Market Cap: CHF 230.9b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

AstraZeneca

Market Cap: UK£219.7b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Merck

Market Cap: US$292.0b

Operates as a healthcare company worldwide.

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Thermo Fisher Scientific

Market Cap: US$205.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Amgen

Market Cap: US$202.4b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Gilead Sciences

Market Cap: US$188.2b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Pfizer

Market Cap: US$153.8b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Danaher

Market Cap: US$153.2b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Bristol-Myers Squibb

Market Cap: US$123.7b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Vertex Pharmaceuticals

Market Cap: US$119.5b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

GSK

Market Cap: UK£87.0b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Sanofi

Market Cap: €99.4b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Chugai Pharmaceutical

Market Cap: JP¥14.8t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Regeneron Pharmaceuticals

Market Cap: US$80.1b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Merck KGaA

Market Cap: €54.6b

Operates as a science and technology company in Germany and internationally.

UCB

Market Cap: €50.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

CSL

Market Cap: AU$82.6b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Takeda Pharmaceutical

Market Cap: JP¥8.8t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Zoetis

Market Cap: US$56.1b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥387.5b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Samsung BiologicsLtd

Market Cap: ₩79.2t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Bayer

Market Cap: €45.4b

Operates as a life science company worldwide.

argenx

Market Cap: €43.4b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Haleon

Market Cap: UK£35.7b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Lonza Group

Market Cap: CHF 36.3b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Galderma Group

Market Cap: CHF 35.2b

Operates as a dermatology company worldwide.

Sun Pharmaceutical Industries

Market Cap: ₹4.1t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

WuXi AppTec

Market Cap: CN¥303.2b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$42.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Teva Pharmaceutical Industries

Market Cap: US$40.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

BeOne Medicines

Market Cap: US$38.6b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.